01672.HK
Ascletis Pharma Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 4.90
−6.04%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.26x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 0.91x
Liquidity & coverage
- Current ratio
- 12.92x
- Quick ratio
- 12.91x
- Cash ratio
- 12.76x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- HKD 2.5B
Cash & dividend
- FCF / debt
- -134.40x
- Cash flow / debt
- -133.89x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026